Found: 219
ОБЗОР2025 · pp. 30–38
Potupchik T.V., Usoltseva O.N., Kupov S.S., Veselova O.F., Efremova S.S., Baskakova E.S., Boyarko A.P.
The purpose of the study. To analyze scientific data on the molecular targets and mechanisms of action of key natural bioactive substances used to support cancer patients after chemotherapy and radiation therapy in the framework of personalized medicine. Perso…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 71–77
Asanova E.R., Maksimova P.E., Zima D.V., Khabarov O.R., Fedotov V.V., Zayblitskaya E.Yu.
Introduction. Due to the rapidly growing incidence of tumor pathology of the thyroid gland, the range of molecular genetic research methods used to study the targets of targeted drugs, prognosis and surgical tactics is growing. Aim. To study the frequency of m…
ОБЗОР2025 · pp. 12–20
Stepanov A.V., Shapovalov K.G., Stepanov E.A.
Relevance. The mechanisms of B-lymphocyte immunity are not fully understood at present, in particular, the role and significance of the humoral response to viruses. There is insufficient understanding of how B-lymphocytes are selected for differentiation into …
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 56–64
Mitrofanova L.B., Makarov I.A., Guseva K.A., Danilova I.A., Gulyaev D.A.
Introduction. The pathogenesis of infection of the central nervous system (CNS) with SARS-CoV2 and nervourological complications are still poorly understood, as well as the link of viral infection with the risk and the course of gliomas. The aim. Evaluating of…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2025 · pp. 34–40
Kudriashov G.G., Krylova Yu.S., Zmitrichenko Yu.G., Tochilnikov G.V., Afafonov G.M., Vinogradova T.I., Yablonskii P.K.
Introduction. Up to 20% of tuberculosis patients suffer from malignant neoplasms. In this case, the combination of both diseases in the lung is a particular problem. More than 60% of patients cannot complete combination therapy due to drug-resistant MBT. The a…
ОБЗОР2025 · pp. 27–33
Gafurova O.A., Danilik O.N., Anufrieva O.V., Syrovatskaya Ya.V., Orobets M.A., Artykova R.A., Gosteeva E.A., Rudenko E.E., Smolyannikova V.A.
Currently, the diagnosis of early stages of cutaneous T-cell lymphomas (CTCL) is one of the most challenging tasks in dermatology. This review is devoted to the analysis of new immunohistochemical (IHC) markers that could be considered diagnostic for the detec…
ОБЗОР2025 · pp. 3–15
Seliverstov P.V., Ananyan M.A., Marchenko S.D., Stepanov M.R., Voznesenskaya E.A., Ilina K.V., Lyapustin K.Yu.
Introduction. Nanotechnology represents an innovative direction in cancer drug development, enabling the creation of effective drug delivery systems with enhanced therapeutic properties. Objective. To analyze the main types of nanoparticles used in oncology, e…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 68–74
Mikashinovich Z.I., Telesmanich N.R., Smirnova O.B.
Introduction. In clinical experiments with various pathologies leading to the activation of POL, it was found that one of the most important areas of correction of oxidative stress is the use of drugs with the properties of antioxidants and antihypoxants [6, 7…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 61–67
Popuchiev V.V., Yatsenko E.M., Fomina N.K., Mikhina L.N., Zhavoronkov L.P., Yuzhakov V.V., Konoplyannikov A.G.
Relevance. The search for new antitumor drugs and their selective delivery directly to the tumor site is an important task of modern oncology. For these purposes, currently, the use of various nanoparticles as carriers of medicinal substances is of great impor…
ОБЗОР2024 · pp. 40–51
Seliverstov P.V., Baksheeva A.D., Koretskaya P.S., Abdusattarov I.Z.
Objective. To analyze current advances in nanotechnology applications for the development of targeted drugs in oncology, including their mechanisms of action and clinical application prospects. Material and methods. A comprehensive analysis of scientific liter…
ОБЗОР2024 · pp. 21–28
Garifullina A.G., Gilyazova I.R., Abdeeva G.R., Kudlay D.A., Nizamova A.R., Minyazova A.A., Bakirov B.A.
Introduction. Chronic lymphocytic leukemia (CLL) is the most common leukemia type in adults. CLL is characterized by significant changes in the patient's genome, including both various mutations and epigenetic changes. These changes currently play an important…
ОБЗОР2024 · pp. 3–13
Glazanova T.V., Pavlova I.E., Kuzmich E.V., Kushlinskii N.E.
Introduction. Immune checkpoint (IC) signaling pathways are involved in regulating the functions of T lymphocytes and NK cells, which play a key role in antitumor and antiviral control. The purpose of our study was to systematically analyze the information pre…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 40–47
Merkureva O.N., Kuznetsov I.N., Babkina I.V., Rogozhin D.V., Sushentsov E.A., Gershtein E.S., Kushlinskii N.E.
Introduction. Angiogenesis regulators are of particular interest as new serum markers in cancer patients, since they reflect the intensity of tumor growth and metastasis. Currently, many works are dedicated to the study of vascular endothelial growth factor (V…
ОБЗОР2024 · pp. 24–30
Sergeeva E.Yu.
The development of metastases even long after treatment is one of the most important problems of medicine. There are mechanisms helping cancer cells to survive at various steps of metastasis. The ability of cancer cells to turn into dormant state characterizin…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 45–52
Sinyavskaya A.M., Troitskii A.V., Bystrova T.N., Novikova E.G., Selyatitskaya V.G.
Introduction. An actual decision of the issue of safety and effective drug therapy improvement is the development of transport systems that allow to provide targeted delivery of drugs to target cells, while reducing their toxic effects. The aim of the work was…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 38–44
Lapkina E.Z., Kutsenko V.A., Ruksha T.G.
Introduction. Cancer cell drug resistance in melanoma is associated with evasion of apoptosis-induced stimuli. Assessing the level of expression of the BCL2 and SIRT1 genes in distant organs and the tumor node makes it possible to assess the resistance of mela…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 34–39
Belkin A.N., Freynd G.G., Kochetov A.G.
Introduction. Alkaline phosphatase (ALP) is an enzyme from the class of hydrolases, widely present in human tissues and organs. Intestinal ALP is one of the enzyme isoforms that is expressed in the mucous membrane throughout the intestine and is a marker of in…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 28–33
Novak-Bobarykina U.A., Dokhov M.A., Krylova Yu.S., Kvetnaya T.V., Paltsev M.A.
Relevance. Ectopic secretion, which occurs in the early stages of tumor development, is not only one of the first signs of a neoplasm, but can also indicate the severity of the oncological process. Purpose of the study: To evaluate the possibility of using the…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 21–28
Krylova Yu.S., Kudriashov G.G., Tochilnikov G.V., Vinogradova T.I., Dokhov M.A., Yablonskii P.K.
Introduction. Lung cancer occupies a leading position in the structure of mortality from cancer. Chronic inflammation characteristic of tuberculosis increases the risk of lung cancer. Currently, more and more information is emerging confirming the cause-and-ef…
ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ2024 · pp. 35–42
Kudriashov G.G., Zmitrichenko Yu.G., Vinogradova T.I., Dogonadze M.Z., Zabolotnyh N.V., Dyakova M.E., Esmedlyaeva D.S., Tochilnikov G.V., Nefedov A.O., Krylova Yu.S., Yablonskii P.K.
Introduction. Treatment of the coexistent pathology of lung cancer and tuberculosis remains the prerogative of experimental research, since the optimal treatment strategy for the coexistence of these two diseases has not yet been developed. The purpose was to …